1 |
Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004; 43: 879-923.
DOI
ScienceOn
|
2 |
American Society of Health-System Pharmacists. Tramadol hydrochloride, In: American Society of Health-System Pharmacists. AHFS Drug Information, 2010; 28:16.04.16.
|
3 |
American Pharmacists Association. Venlafaxine, In: American Pharmacists Association. Drug Information Handbook: Lexi-Comp , 2008; 1624-1627.
|
4 |
Naranjo CA, Busto U, Sellers EM, et al., A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
DOI
ScienceOn
|
5 |
Leppert W, Majkowicz M. The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain. Int J Clin Pract 2010; 64: 1681-1687.
DOI
ScienceOn
|
6 |
Pandey R, Elakkumanan LB, Garg R, et al., Prolonged apnea after small single dose of intravenous tramadol. AANA J 2010; 78: 110-112.
|
7 |
Afshari R, Ghooshkhanehee H. Tramadol overdose induced seizure, dramatic rise of CPK and acute renal failure. J Pak Med Assoc 2009; 59: 178.
|
8 |
Stamer UM, Stuber F, Muders T, et al., Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication. Anesth Analg 2008; 107: 926-929.
DOI
ScienceOn
|
9 |
Barnung SK, Treschow M, Borgbjerg FM. Respiratory depression following oral tramadol in a patient with impaired renal function. Pain 1997; 71: 111-112.
DOI
ScienceOn
|
10 |
Rollason V, Samer C, Piguet V, et al., Pharmacogenetics of analgesics: toward the individualization of prescription. Pharmacogenomics 2008; 9: 905-933.
DOI
ScienceOn
|
11 |
Gholami K, Shalviri G, Zarbakhsh A, et al., New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center. Pharmacoepidemiol Drug Saf 2007; 16: 229-237.
DOI
ScienceOn
|
12 |
Stamer UM, Lehnen K, Höthker F, et al., Impact of CYP2D6 genotype on ostoperative tramadol analgesia. Pain 2003; 105: 231-238.
DOI
ScienceOn
|